J 2007

Gonadoliberine analogues administration for ovarian function protection during chemotherapy

HUSER, Martin, Igor CRHA, Robert HUDEČEK, Pavel VENTRUBA, Jana ŽÁKOVÁ et. al.

Basic information

Original name

Gonadoliberine analogues administration for ovarian function protection during chemotherapy

Name in Czech

Gonadoliberine analogues administration for ovarian function protection during chemotherapy

Authors

HUSER, Martin (203 Czech Republic, guarantor), Igor CRHA (203 Czech Republic), Robert HUDEČEK (203 Czech Republic), Pavel VENTRUBA (203 Czech Republic), Jana ŽÁKOVÁ (203 Czech Republic), Lenka ŠMARDOVÁ (203 Czech Republic), Zdeněk KRÁL (203 Czech Republic) and Jiří JARKOVSKÝ (203 Czech Republic)

Edition

Human Reproduction, Oxford, Oxford Journals, 2007, 0268-1161

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30214 Obstetrics and gynaecology

Country of publisher

Denmark

Confidentiality degree

is not subject to a state or trade secret

Impact factor

Impact factor: 3.543

RIV identification code

RIV/00216224:14110/07:00019082

Organization unit

Faculty of Medicine

UT WoS

255322200289

Keywords in English

Human Reproduction

Tags

human reproduction

Tags

International impact, Reviewed
Changed: 2/7/2009 16:46, prof. MUDr. Martin Huser, Ph.D., MBA

Abstract

ORIG CZ

V originále

Human Reproduction, Human ReproductionHuman ReproductionHuman Reproduction. Gonadoliberine analogues administration for ovarian function protection during chemotherapyGonadoliberine analogues administration for ovarian function protection during chemotherapy

In Czech

Human Reproduction, Human ReproductionHuman ReproductionHuman ReproductionHuman Reproduction. Gonadoliberine analogues administration for ovarian function protection during chemotherapyGonadoliberine analogues administration for ovarian function protection during chemotherapy.kk

Links

NR8469, research and development project
Name: Možnosti ochrany reprodukčních funkcí u žen podstupujících chemoterapii pro hematologickou malignitu
Displayed: 15/3/2025 19:43